Prefilled Syringes Market Report by Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, Customized Prefilled Syringes), Material (Glass Prefilled Syringes, Plastic Prefilled Syringes), Closing System (Staked Needle System, Luer Cone System, Luer Lock Form System), Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Oncology, and Others), End User (Hospitals, Clinics, and Others), and Region 2025-2033
Market Overview:
The global prefilled syringes market size reached USD 8.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. At present, Europe holds the largest market share across the globe due to the increasing demand for biologics, a growing preference for convenient and safe self-administration, and stringent regulatory standards promoting the adoption of advanced, contamination-free drug delivery systems.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2024
|
|
Forecast Years
|
2025-2033
|
|
Historical Years
|
2019-2024
|
|
Market Size in 2024
|
USD 8.2 Billion |
|
Market Forecast in 2033
|
USD 15.8 Billion |
| Market Growth Rate 2025-2033 | 7.58% |
A prefilled syringe is a single-dose packet of injectable vaccines that is disposable in nature. The usage of prefilled syringes significantly lowers the chances of drug contamination as it avoids the potential admixture-related contamination risks when syringes are inserted into a drug vial to draw out a dose. Combining this with a pre-sterilized syringe further increases safety, enables the easy and quick delivery of drugs in the case of emergencies, and eliminates the additional on-site vial cleaning and de-pyrogenation processes. Consequently, they are a preferred option to administer the drugs via the parenteral route for delivering a wide range of injectables, such as biosimilar and biologics.
Prefilled Syringes Market Trends:
Rising Demand for Injectable Drugs
The global demand for injectable drugs, especially biologics, vaccines, and therapeutic agents, represents one of the major factors driving the prefilled syringes market growth. Injectable medications are often preferred for their fast-acting effects, crucial for chronic diseases, cancers, and autoimmune conditions, which require precise, controlled dosages. In line with this, prefilled syringes offer a convenient, ready-to-use solution that reduces the risks of dosage errors, contamination, and preparation time. Furthermore, the rising prevalence of chronic diseases and increased focus on patient-centric healthcare drive the adoption of injectable drug formats, pushing pharmaceutical companies to increasingly use prefilled syringes for efficiency and safety.
Increasing Preference for Safety and Convenience
Patient safety and convenience are major factors influencing the growth of the market. Healthcare providers and patients prefer prefilled syringes due to their enhanced safety features, including reduced contamination risks and accurate dosing. This format reduces the risk of needlestick injuries, cross-contamination, and other hazards associated with traditional vials and syringes. In addition to this, with a growing emphasis on home healthcare and self-administration, prefilled syringes are becoming increasingly popular among patients, as they simplify the process, supporting ease of use and minimizing potential health risks. This, in turn, is contributing to the market growth significantly.
Advancements in Prefilled Syringe Technology
Significant technological advancements are expected to increase the overall prefilled syringes market share across the globe. Innovations in materials, like the use of glass alternatives and ultra-thin needles, improve syringe durability and patient comfort. The development of safety-engineered devices and auto-disable syringes further ensures accurate dosing and prevents accidental misuse. Moreover, advancements in prefilled syringe manufacturing, such as automated filling and sealing processes, enhance product quality and scalability. These technological improvements are essential as the pharmaceutical industry shifts toward complex biologics that require specialized, sterile packaging, making advanced prefilled syringes the preferred choice for numerous therapeutic applications.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global prefilled syringes market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on design, material, closing system, application, and end user.
Breakup by Design:
- Single-chamber Prefilled Syringes
- Dual-chamber Prefilled Syringes
- Customized Prefilled Syringes
Breakup by Material:
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
Breakup by Closing System:
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
Breakup by Application:
- Diabetes
- Anaphylaxis
- Rheumatoid Arthritis
- Oncology
- Others
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global prefilled syringes market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International Inc.
- Bayer AG
- Becton Dickinson and Company
- Cardinal Health Inc.
- Catalent Inc.
- Fresenius SE & Co. KGaA
- Gerresheimer AG
- Nipro Corporation
- Schott AG
- Terumo Corporation
- West Pharmaceutical Services Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Prefilled Syringes Market News:
- In September 2024, BD, a leading global medical technology company, announced the commercial release of the BD Neopak XtraFlow™ Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak™ Glass Prefillable Syringe platform to serve the growing market for biologic therapies.
- In April 2024, Laboratorios Farmacéuticos Rovi, S.A., a pan-European pharmaceutical company that specializes and engages in the research, development, contract manufacturing, and licensing of small molecules and biological medicines, announced that its subsidiary ROVI Pharma Industrial Services, S.A.U. agreed to support the manufacture of pre-filled syringes for a global pharmaceutical company.
Report Scope:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2024 |
| Historical Period | 2019-2024 |
| Forecast Period | 2025-2033 |
| Units | Billion USD |
| Segment Coverage | Design, Material, Closing System, Application, End User, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation and West Pharmaceutical Services Inc. |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report
The global prefilled syringes market was valued at USD 8.2 Billion in 2024.
We expect the global prefilled syringes market to exhibit a CAGR of 7.58% during 2025-2033.
The rising adoption of prefilled syringes that increase safety and enable the easy and quick delivery of drugs in the case of emergencies is primarily driving the global prefilled syringes market.
The sudden outbreak of the COVID-19 pandemic has led to the growing demand for prefilled syringes to deliver the coronavirus infection vaccines to the individuals across several nations.
Based on the design, the global prefilled syringes market has been segmented into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Currently, single-chamber prefilled syringes hold the majority of the total market share.
Based on the material, the global prefilled syringes market can be divided into glass prefilled syringes and plastic prefilled syringes, where glass prefilled syringes currently exhibit a clear dominance in the market.
Based on the closing system, the global prefilled syringes market has been categorized into staked needle system, luer cone system, and luer lock form system. Among these, staked needle system accounts for the majority of the global market share.
Based on the end user, the global prefilled syringes market can be segregated into hospitals, clinics, and others. Currently, hospitals hold the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global prefilled syringes market include Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation, and West Pharmaceutical Services Inc.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Inquire Before Buying
Speak to an Analyst
Request Brochure
Request Customization
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
